Father-Focused Intervention for Reducing Family Violence and Symptoms in Children

Recruiting now · Not applicable

Conditions studied: Intimate Partner Violence, Child Maltreatment

In brief

The goal of this clinical trial is to test the efficacy of Fathers for Change (F4C) compared to standard Batterer Intervention for fathers with a history of Intimate Partner Violence. The main question\[s\] it aims to answer are: 1. Is F4C more efficacious than standard BIP in reducing family violence and child mental health impairment? 2. What are the trajectories of therapeutic change targets across interventions? 3. Does father's emotion regulation and reflective functioning mediate the relationship between the two interventions and child-related outcomes? Participants will be randomized to either Fathers for Change on Batterer Intervention.

Key facts

Study ID

NCT06074068

Run by

Yale University

People needed

1080

Starts

2024-01-11

Expected to finish

2028-12-31

Last updated by the study team

2026-04-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• have at least one 6 month to 12-year-old biological child with whom they have contact;
• had an incident of IPV within the last 12 months prior to screening with their child's mother (based on court/police records, coparent or self-report);
• have a currently open or recently investigated (in the last 6 months) case with CT DCF
• are able to complete assessments in English or Spanish;
• agree to have their female coparents (mother of target child) contacted as collateral informants and for consent for participation of their child. If a participant has more than one child in the age range, the youngest will be selected;
• female coparents (i.e., biological mother who need not be in a relationship with the father) consents to (at minimum) provide parent-report on child; however, may opt out of child participation. If the coparent agrees to participate by providing caregiver-report on child symptoms, but declines participation of their shared child, the father may still participate in the study if he meets eligibility criteria outlined below; thus, preventing any possible retaliation against co-parents for not consenting to child participation.

You may not qualify if…

• Fathers will be excluded based on the following exclusion criteria:
• an active full/no contact protective order pertaining to their child because this will preclude participation in the father-child play assessment (many men will have protective orders pertaining to their partners, but it is more common for men to still be allowed contact with their children);
• physiological addiction to a substance that requires detoxification. Fathers will be evaluated using the Drug Abuse Screening Test and AUDIT. If fathers report significant difficulties with physiological withdrawal (e.g., alcohol tremors or dope sickness) they will be referred for detox services. They can be re-evaluated following a detox program with documentation from the detox center of successful completion and clean urine screen;
• cognitive impairment that will not allow for understanding of the study interventions (a mini mental state score <25);
• current untreated psychotic disorder;
• currently suicidal or homicidal ideation based on screening using the BSI; or
• previously participated in F4C or a BIP.

Where it is running

• Yale — New Haven, Connecticut, United States (enrolling)
• UCONN Health Center — West Hartford, Connecticut, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.